Individualized treatment rule characterization via a value function surrogate
Nikki L B Freeman1, Sydney E Browder2, Katharine L McGinigle3
1Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, United States.
Precision medicine strategies can be improved by Bayesian optimization for learning optimal individualized treatment rules, especially in contexts like peripheral artery disease wound management with partial compliance. This approach also characterizes treatment rule classes for clinical translation.
Area of Science:
- Biomedical Informatics
- Clinical Research
- Statistical Learning
Background:
- Precision medicine aims to improve healthcare by tailoring treatments, but a gap exists between statistical strategies and real-world implementation.
- Challenges in implementing precision medicine include context-specific factors, such as partial patient compliance with treatment plans.
- Peripheral artery disease (PAD) wound management presents a relevant clinical context for addressing these implementation challenges.
Purpose of the Study:
- To demonstrate the feasibility of using Bayesian optimization with Gaussian process surrogates to learn optimal individualized treatment rules (ITRs).
- To address the specific challenge of partial compliance in wound management for patients with peripheral artery disease.
- To extend the application beyond learning single optimal ITRs to characterizing classes of ITRs and their clinical translation.
Main Methods:
- Employed Bayesian optimization, utilizing a Gaussian process surrogate for the value function.
- Focused on the clinical scenario of peripheral artery disease patients with partial compliance to wound management protocols.
- Developed methods to characterize classes of ITRs, not just a single optimal rule.
Main Results:
- Showcased the feasibility of Bayesian optimization for learning optimal ITRs in the specified clinical context.
- Demonstrated the ability to characterize distinct classes of ITRs.
- Provided insights into translating these findings into practical clinical applications.
Conclusions:
- Bayesian optimization offers a viable approach to developing effective individualized treatment rules, even with partial compliance.
- Characterizing classes of ITRs enhances the practical utility and adaptability of precision medicine strategies.
- The proposed methods facilitate the translation of advanced statistical learning into real-world clinical decision-making for improved patient outcomes.
More Related Videos
13:04Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
Published on: September 19, 2012
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Decision Making: P-value Method
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Woodward–Hoffmann Selection Rules and Microscopic Reversibility
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
